' Astonishing ' 4-Year Survival in NSCLC With Pembro+Chemo ' Astonishing ' 4-Year Survival in NSCLC With Pembro+Chemo

New data showing a doubling in survival with the combination versus chemo alone have been hailed as"very impressive", even"astonishing", by clinicians.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news